Conditions & Recovery · NY Times Health · September 4, 2026

The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists

Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.

Originally published by NY Times Health. We curate and add context; they did the reporting.

Read the full story at NY Times Health ↗

Related learning

Biotech Firm Claims Some Credit for Groundbreaking Virus Research Biotech Firm Claims Some Credit for Groundbreaking Virus Research James P. Allison, Ph.D., bangs gong after completing proton therapy treatment Combination therapy helps plasmacytoid bladder cancer survivor